2003
DOI: 10.1016/s0040-4039(03)00538-0
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a potential reactivator of acetylcholinesterase—1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
78
0

Year Published

2005
2005
2010
2010

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(81 citation statements)
references
References 11 publications
3
78
0
Order By: Relevance
“…In this study, we have tested three currently used AChE reactivators (pralidoxime, obidoxime, and HI-6) in comparison with our newly developed AChE reactivators (K033 and K027) [11,12]. We have previously tested their potencies on rat brain homogenate [13,14].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In this study, we have tested three currently used AChE reactivators (pralidoxime, obidoxime, and HI-6) in comparison with our newly developed AChE reactivators (K033 and K027) [11,12]. We have previously tested their potencies on rat brain homogenate [13,14].…”
Section: Discussionmentioning
confidence: 99%
“…HI-6 and the new oximes, K033 and K027, were synthesized at our department [11,12,13,16]. The purity of all AChE reactivators was tested using TLC (DC-Alufolien Cellulose F; mobile phase n-butanol: acetic acid: water-5:1:2; Detection: Dragendorff reagent).…”
Section: Chemicalsmentioning
confidence: 99%
See 1 more Smart Citation
“…For instance, some isn basedcompounds are promising reactivators for the acetylcholinesterase inhibited by sarin [5] and paraoxon organophosphorus agent [6]. Another relevant property of isn is related to its ability to enhance Sirt1 deacetylase activity by competing with the endogenous Sirt1 inhibitor nicotinamide [7].…”
Section: Introductionmentioning
confidence: 99%
“…In 2003, a new promising AChE reactivator against tabun was prepared -K027 (5; Figure 3) [23]. This reactivator, together with trimedoxime (4), is considered to be currently the most potent available for experimental treatment of GA poisoning [24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%